Literature DB >> 19234350

Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.

William M Dismuke1, Najam A Sharif, Dorette Z Ellis.   

Abstract

PURPOSE: There is a correlation between cell volume changes and changes in the rate of aqueous humor outflow; agents that decrease trabecular meshwork (TM) cell volume increase the rate of aqueous humor outflow. This study investigated the effects of the nitric oxide (NO)-independent activators of soluble guanylate cyclase (sGC), YC-1, and BAY-58-2667 on TM cell volume and the signal transduction pathways and ion channel involved.
METHODS: Cell volume was measured with the use of calcein AM fluorescent dye, detected by confocal microscopy. Inhibitors and activators of sGC, 3',5'-cyclic guanosine monophosphate (cGMP), protein kinase G (PKG), and the BK(Ca) channel were used to characterize their involvement in the YC-1- and BAY-58-2667-induced regulation of TM cell volume. cGMP was assayed by an enzyme immunoassay.
RESULTS: YC-1 (10 nM-200 microM) and BAY-58-2667 (10 nM-100 microM) each elicited a biphasic effect on TM cell volume. YC-1 (1 microM) increased TM cell volume, but higher concentrations decreased TM cell volume. Similarly, BAY-58-2667 (100 nM) increased TM cell volume, but higher concentrations decreased cell volume. The YC-1-induced cell volume decrease was mimicked by 8-Br-cGMP and abolished by the sGC inhibitor ODQ, the PKG inhibitor (RP)-8-Br-PET-cGMP-S, and the BK(Ca) channel inhibitor IBTX. The BAY-58-2667-induced cell volume decrease was mimicked by 8-Br-cGMP and was abolished by the PKG inhibitor and the BK(Ca) channel inhibitor. Unlike the YC-1 response, ODQ potentiated the BAY-58-2667-induced decreases in cell volume.
CONCLUSIONS: These data suggest that the NO-independent decrease in TM cell volume is mediated by the sGC/cGMP/PKG pathway and involves K(+) efflux.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234350     DOI: 10.1167/iovs.08-3127

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.

Authors:  Peter G Klimko; Najam A Sharif
Journal:  Br J Pharmacol       Date:  2018-05-17       Impact factor: 8.739

Review 2.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

3.  Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy.

Authors:  Michael DeNiro; Falah H Al-Mohanna; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

4.  YC-1 targeting of hypoxia-inducible factor-1α reduces RGC-5 cell viability and inhibits cell proliferation.

Authors:  Leo Tsui; Tsorng-Harn Fong; I-Jong Wang
Journal:  Mol Vis       Date:  2012-06-15       Impact factor: 2.367

Review 5.  Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.

Authors:  Emmanuel S Buys; Lincoln R Potter; Louis R Pasquale; Bruce R Ksander
Journal:  Front Mol Neurosci       Date:  2014-05-19       Impact factor: 5.639

6.  Technical brief: Direct, real-time electrochemical measurement of nitric oxide in ex vivo cultured human corneoscleral segments.

Authors:  Pinkal D Patel; Ramesh B Kasetti; Swapnil K Sonkusare; Gulab S Zode
Journal:  Mol Vis       Date:  2020-06-05       Impact factor: 2.367

Review 7.  Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision.

Authors:  Najam A Sharif
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 8.  The Application of Nitric Oxide for Ocular Hypertension Treatment.

Authors:  Binze Han; Maomao Song; Liping Li; Xinghuai Sun; Yuan Lei
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

9.  The Soluble Guanylate Cyclase Stimulator IWP-953 Increases Conventional Outflow Facility in Mouse Eyes.

Authors:  Pei Ge; Iris D Navarro; Marco M Kessler; Sylvie G Bernier; Nicholas R Perl; Renee Sarno; Jaime Masferrer; Gerhard Hannig; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

10.  The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase.

Authors:  Stefan Muenster; Wolfgang S Lieb; Gregor Fabry; Kaitlin N Allen; Shivani S Kamat; Ann H Guy; Ana C Dordea; Leandro Teixeira; Robert E Tainsh; Binglan Yu; Wei Zhu; Nicole E Ashpole; Rajeev Malhotra; Peter Brouckaert; Donald B Bloch; Marielle Scherrer-Crosbie; W Daniel Stamer; Markus H Kuehn; Louis R Pasquale; Emmanuel S Buys
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.